Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
The expression status of human epidermal growth factor receptor 2 in epithelial ovarian cancer in Ibadan, Nigeria
It has been proposed that the overexpression of the human epidermal growth factor receptor 2 (HER2/neu proto oncogene) could be a possible therapeutic target in epithelial ovarian cancer, as has been the case in breast carcinomas. However, there is lack of knowledge on the status of the gene in neop...
Saved in:
| Format: | Article |
|---|---|
| Published: |
2016
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: The expression status of human epidermal growth factor receptor 2 in epithelial ovarian cancer in Ibadan, Nigeria
- The expression status of human epidermal growth factor receptor 2 in epithelial ovarian cancer in Ibadan, Nigeria
- Clinicopathological pattern of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 over-expression of epithelial ovarian carcinomas in Nigeria
- Pattern of triple negative epithelial ovarian cancer in indigenous African women [version 1; referees: 2 approved
- Hormone-receptor expression status of epithelial ovarian cancer in Ibadan, South-western Nigeria
- Hormone–receptor expression status of epithelial ovarian cancer in Ibadan, South-western Nigeria
- Hormone–receptor expression status of epithelial ovarian cancer in Ibadan, South-Western Nigeria